Manulife (Manufacturers Life Insurance)’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-624
| Closed | -$61.1K | – | 3133 |
|
|
2022
Q1 | $61.1K | Sell |
624
-201
| -24% | -$25.8K | ﹤0.01% | 3026 |
|
|
2021
Q4 | $135 | Sell |
825
-25
| -3% | -$5.49K | ﹤0.01% | 3005 |
|
|
2021
Q3 | $232K | Buy |
850
+34
| +4% | +$10.4K | ﹤0.01% | 2876 |
|
|
2021
Q2 | $323K | Buy |
816
+5
| +0.6% | +$2.33K | ﹤0.01% | 2762 |
|
|
2021
Q1 | $438K | Sell |
811
-67
| -8% | -$41.7K | ﹤0.01% | 2370 |
|
|
2020
Q4 | $332K | Buy |
878
+26
| +3% | +$10.3K | ﹤0.01% | 2449 |
|
|
2020
Q3 | $322K | Hold |
852
| – | – | ﹤0.01% | 2245 |
|
|
2020
Q2 | $410K | Buy |
852
+102
| +14% | +$45.5K | ﹤0.01% | 2063 |
|
|
2020
Q1 | $276K | Buy |
750
+104
| +16% | +$53.8K | ﹤0.01% | 2145 |
|
|
2019
Q4 | $458K | Sell |
646
-23
| -3% | -$15.8K | ﹤0.01% | 2099 |
|
|
2019
Q3 | $423K | Sell |
669
-1
| -0.1% | -$793 | ﹤0.01% | 2120 |
|
|
2019
Q2 | $586K | Buy |
670
+75
| +13% | +$51.6K | ﹤0.01% | 1950 |
|
|
2019
Q1 | $344K | Sell |
595
-45
| -7% | -$18.8K | ﹤0.01% | 2220 |
|
|
2018
Q4 | $180K | Buy |
640
+30
| +5% | +$11.9K | ﹤0.01% | 2354 |
|
|
2018
Q3 | $293K | Sell |
610
-88
| -13% | -$37.7K | ﹤0.01% | 2547 |
|
|
2018
Q2 | $317K | Buy |
698
+22
| +3% | +$13.9K | ﹤0.01% | 2738 |
|
|
2018
Q1 | $397K | Sell |
676
-10
| -1% | -$6.23K | ﹤0.01% | 2488 |
|
|
2017
Q4 | $426K | Buy |
686
+2
| +0.3% | +$1.44K | ﹤0.01% | 2427 |
|
|
2017
Q3 | $630K | Sell |
684
-12
| -2% | -$10.7K | ﹤0.01% | 2112 |
|
|
2017
Q2 | $649K | Buy |
696
+53
| +8% | +$52K | ﹤0.01% | 2097 |
|
|
2017
Q1 | $613K | Buy |
643
+78
| +14% | +$72.6K | ﹤0.01% | 2042 |
|
|
2016
Q4 | $453K | Buy |
565
+3
| +0.5% | +$2.7K | ﹤0.01% | 2169 |
|
|
2016
Q3 | $475K | Buy |
562
+1
| +0.2% | +$804 | ﹤0.01% | 2118 |
|
|
2016
Q2 | $461K | Buy |
561
+48
| +9% | +$52.3K | ﹤0.01% | 2088 |
|
|
2016
Q1 | $558K | Buy |
513
+5
| +1% | +$5.12K | ﹤0.01% | 1930 |
|
|
2015
Q4 | $633 | Buy |
508
+5
| +1% | +$8.27K | ﹤0.01% | 1876 |
|
|
2015
Q3 | $680 | Buy |
503
+13
| +3% | +$21.5K | ﹤0.01% | 1806 |
|
|
2015
Q2 | $883 | Buy |
490
+106
| +28% | +$165K | ﹤0.01% | 1756 |
|
|
2015
Q1 | $620 | Buy |
384
+22
| +6% | +$32.6K | ﹤0.01% | 1969 |
|
|
2014
Q4 | $276 | Sell |
362
-9
| -2% | -$4.78K | ﹤0.01% | 2417 |
|
|
2014
Q3 | $147 | Buy |
371
+8
| +2% | +$3.86K | ﹤0.01% | 2849 |
|
|
2014
Q2 | $219K | Sell |
363
-56
| -13% | -$31.2K | ﹤0.01% | 2653 |
|
|
2014
Q1 | $288 | Buy |
419
+62
| +17% | +$41.5K | ﹤0.01% | 2471 |
|
|
2013
Q4 | $233 | Buy |
357
+3
| +0.8% | +$1.79K | ﹤0.01% | 2602 |
|
|
2013
Q3 | $209 | Sell |
354
-10
| -3% | -$4.51K | ﹤0.01% | 2624 |
|
|
2013
Q2 | $115K | Buy |
+364
| New | +$101K | ﹤0.01% | 2961 |
|
Other funds holding TCRT
MP
DCM
LCM
Manulife (Manufacturers Life Insurance)'s TCRT Position: Q2 2022 in Review
Manulife (Manufacturers Life Insurance) sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 624 shares — an estimated $61.1K sold.
Manulife (Manufacturers Life Insurance) first reported a position in TCRT in Q2 2013 and held it in 36 quarters. The position peaked at $649K in Q2 2017. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- Manulife (Manufacturers Life Insurance) reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 624 Alaunos Therapeutics shares in Q2 2022, an estimated $61.1K.
- Manulife (Manufacturers Life Insurance) first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 36 quarters.
- Manulife (Manufacturers Life Insurance)'s Alaunos Therapeutics position peaked at $649K in Q2 2017.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2022, filed 15 Aug 2022.